N-Acetyl-DL-penicillamine
(Synonyms: 乙酰青霉胺) 目录号 : GC47736A chelating agent
Cas No.:59-53-0
Sample solution is provided at 25 µL, 10mM.
N-Acetyl-DL-penicillamine is a chelating agent.1,2,3 It inhibits the binding of methyl mercury to isolated human erythrocytes by 50% and removes 50% of methyl mercury ions from methyl mercury-loaded blood cells when used at a concentration of 1 mM.1,2 N-Acetyl-DL-penicillamine (3 mmol/kg per day, p.o.) reduces the biological half-life of mercury and decreases liver, kidney, brain, and blood mercury levels, as well as increases urinary excretion of mercury in a concentration-dependent manner, in mice when administered following injection of methyl mercuric chloride. It decreases mercuric chloride-induced mortality in mice when administered orally at a dose of 1.6 mmol/kg.3 N-Acetyl-DL-penicillamine is also an analog of SNAP that does not generate nitric oxide and has been used as a negative control in experiments using SNAP.4,5
1.Aaseth, J.Mobilization of methyl mercury in vivo and in vitro using N-acetyl-DL-penicillamine and other complexing agentsActa Pharm. Toxicol. (Copenh.)39(3)289-301(1976) 2.Aaseth, J., Alexander, J., and Deverill, J.Evaluation of methyl mercury chelating agents using red blood cells and isolated hepatocytesChem. Biol. Interact.36(3)287-297(1981) 3.Nielsen, J.B., and Andersen, O.Effect of four thiol-containing chelators on disposition of orally administered mercuric chlorideHum. Exp. Toxicol.10(6)423-430(1991) 4.Ogura, T., DeGeorge, G., Tatemichi, M., et al.Suppression of anti-microtubule agent-induced apoptosis by nitric oxide: Possible mechanism of a new drug resistanceJpn. J. Cancer Res.89(2)199-205(1998) 5.Takhampunya, R., Padmanabhan, R., and Ubol, S.Antiviral action of nitric oxide on dengue virus type 2 replicationJ. Gen. Virol.87(Pt. 10)3003-3011(2006)
Cas No. | 59-53-0 | SDF | |
别名 | 乙酰青霉胺 | ||
Canonical SMILES | SC(C)(C)C(NC(C)=O)C(O)=O | ||
分子式 | C7H13NO3S | 分子量 | 191.2 |
溶解度 | DMF: 30 mg/ml,DMSO: 30 mg/ml,DMSO:PBS (pH 7.2) (1:7): 0.12 mg/ml,Ethanol: 5 mg/ml | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 5.2301 mL | 26.1506 mL | 52.3013 mL |
5 mM | 1.046 mL | 5.2301 mL | 10.4603 mL |
10 mM | 0.523 mL | 2.6151 mL | 5.2301 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet